Find a Physician

Email this profile
Portrait View Larger

Eric R. Gross

Academic Appointments

Key Documents

Contact Information

  • Clinical Offices
    Department of Anesthesia 300 Pasteur Dr H3580 MC 5640 Stanford, CA 94305
    Tel Work (650) 497-8000 Fax (650) 725-8544
  • Academic Offices
    Alternate Contact
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Anesthesia

Academic Appointments

Administrative Appointments

  • Director, Stanford Anesthesia Research Seminars (FNR) (2012 - present)
  • Member, Stanford Society of Physician Scholars (2010 - present)
  • Member, Stanford Pharmacy and Therapeutics Committee (2009 - present)

Honors and Awards

  • Best Overall Abstract of Meeting- Basic Science, International Anesthesia Research Society (IARS) Annual Meeting (2013)
  • K99/R00 Award, NHLBI (2011-Pres)
  • Kosaka Award Finalist, International Anesthesia Research Society (IARS) Annual Meeting (2010)
  • Resident Research Award, 1st Place, New York Society of Anesthesiologists (2010)
  • Young Investigator Award, Runner-Up, International Society For Heart Research (ISHR) Annual Meeting (2005)

Boards, Advisory Committees, Professional Organizations

  • Board Certification in Anesthesiology, ABA (2013 - present)
  • Member, International Society For Heart Research (ISHR) (2012 - present)
  • Member, International Association for the Study of Pain (IASP) (2011 - present)
  • Professional Member, American Heart Association (2003 - present)

Professional Education

Internship: St Joseph's Regional Medical Center WI (2008)
Residency: Stanford University CA (2011)
Medical Education: Medical College of Wisconsin WI (2007)
Anesthesiology: Stanford University, Anesthesiology (2011)
MD: Medical College of Wisconsin, Medicine (2007)
PhD: Medical College of Wisconsin, Pharmacology (2005)
View All 8

Scientific Focus

Current Research and Scholarly Interests

I am an anesthesiologist developing non-narcotic cardiac-safe pain therapeutics. Although opioids are addictive with many unwanted side effects, opioids prior to or during an ischemic event reduce cellular injury, unlike other analgesics such as COX-2 inhibitors which exacerbate injury. By studying how opioids reduce myocardial injury and how the pathways of nociception and cardioprotection are linked, we are designing next generation analgesics that are safe to use for those with cardiovascular disease.

We presently have two agents which we are further studying in the basic science lab
for their potential to be non-narcotic, cardiac safe pain therapeutics.

In addition, we are also interested in investigating the mechanism of how the nociceptive and cardioprotective signaling pathways are linked. We are presently looking at how TRPV1 channels, the ion channel which gives you the hot sensation in your mouth after you eat tat chili pepper and PKC may be part of the cellular cross-talk between these two pathways.

My previous basic science research background involves examining the mechanism of how opioids and volatile anesthetics protect tissue from ischemia-reperfusion injury and what are the molecular mechanisms involved both through in vivo and cellular models of ischemia-reperfusion injury. This is also a continued interest of the laboratory.


Publication tag cloud

Publication Topics

View All 36

Stanford Medicine Resources:

Footer Links: